Novo Nordisk A/S
F:NOVC

Watchlist Manager
Novo Nordisk A/S Logo
Novo Nordisk A/S
F:NOVC
Watchlist
Price: 90.7 EUR -1.52% Market Closed
Market Cap: 203.5B EUR

Wall Street
Price Targets

NOVC Price Targets Summary
Novo Nordisk A/S

There are no price targets for NOVC.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Novo Nordisk A/S Competitors:
Price Targets
300357
Zhejiang Wolwo Bio-Pharmaceutical Co Ltd
7% Upside
LABB
Genomma Lab Internacional SAB de CV
57% Upside
ALM
Almirall SA
9% Upside
ROVI
Laboratorios Farmaceuticos ROVI SA
34% Upside
VY4
SNDL Inc
249% Upside

Revenue
Forecast

Revenue Estimate
Novo Nordisk A/S

For the last 13 years the compound annual growth rate for Novo Nordisk A/S's revenue is 12%. The projected CAGR for the next 4 years is 7%.

12%
Past Growth
7%
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Novo Nordisk A/S

For the last 13 years the compound annual growth rate for Novo Nordisk A/S's operating income is 15%. The projected CAGR for the next 4 years is 4%.

15%
Past Growth
4%
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Net Income
Forecast

Net Income Estimate
Novo Nordisk A/S

For the last 13 years the compound annual growth rate for Novo Nordisk A/S's net income is 15%. The projected CAGR for the next 4 years is 6%.

15%
Past Growth
6%
Estimated Growth
Estimates Accuracy
8%
Average Beat
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is NOVC's stock price target?
Not Available

NOVC doesn't have any price targets made by Wall Street professionals.

What is Novo Nordisk A/S's Revenue forecast?
Projected CAGR
7%

For the last 13 years the compound annual growth rate for Novo Nordisk A/S's revenue is 12%. The projected CAGR for the next 4 years is 7%.

What is Novo Nordisk A/S's Operating Income forecast?
Projected CAGR
4%

For the last 13 years the compound annual growth rate for Novo Nordisk A/S's operating income is 15%. The projected CAGR for the next 4 years is 4%.

What is Novo Nordisk A/S's Net Income forecast?
Projected CAGR
6%

For the last 13 years the compound annual growth rate for Novo Nordisk A/S's net income is 15%. The projected CAGR for the next 4 years is 6%.

Back to Top